Further implications of off-label use of acetazolamide in the management of moyamoya disease in Japan

Shunji Mugikura, Miki Fujimura, Shoki Takahashi, Kei Takase

Research output: Contribution to journalLetterpeer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Further implications of off-label use of acetazolamide in the management of moyamoya disease in Japan'. Together they form a unique fingerprint.